在当代跨导管大动脉假体中获得的血小板缺血
Asen Petrov1, Ali Taghizadeh-Waghefi1, Abdel-Hannan Diab1
1Department of Cardiac Surgery, Heart Centre Dresden, University Hospital of the University of Technology Dresden, Dresden, Sachsen, Germany.
The Thoracic and cardiovascular surgeon
|October 25, 2023
概括
在跨导管大动脉植入 (TAVI) 中使用的气球膨胀 (BEV) 与自膨胀 (SEV) 相比,与更大的术后血小板下降有关. 这一发现突显了BEV假肢对血小板缺血的倾向.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 血液学 血液学 血液学
背景情况:
- 手术后的血小板缺血是通过导管的大动脉植入 (TAVI) 后的一种已知的并发症.
- 血小板动力学及其对不同假肢设备的反应需要进一步研究.
研究的目的:
- 在TAVI手术中比较当前一代气球可扩展 (BEV) 和自扩展 (SEV) 之间的干预后血小板动力学.
- 评估门类型是否影响TAVI后血小板缺血的严重程度.
主要方法:
- 对277名接受TAVI (2017-2019) 的患者进行了回顾性分析.
- 根据假肢类型分层的患者:BEV (n=65) 与SEV (n=212).
- 分析血红素校正的血小板计数,专注于最低计数和血小板计数 (DPC) 的下降.
主要成果:
- 在BEV患者中,干预后血小板下降更为明显 (平均DPC:24.3%与18.8%,p<0.01).
- 在BEV患者中,较高比例的DPC>30% (29.2%对15.6%,p=0.02).
- 两组之间没有观察到术后话语或整体人口特征的显著差异.
结论:
- 当前一代气球可扩展的TAVI假肢与患有术后血栓缺血的倾向有关.
- 即使考虑到稀释的影响,这种倾向仍然存在.
- 进一步的研究可能会探索血小板反应中这种差异背后的机制.
相关概念视频
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Venous Thrombosis I: Introduction
11
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
11
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
537
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
537
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
10
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
10
Anticoagulant Drugs: Low-Molecular-Weight Heparins
723
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
723
Disorders of Hemostasis
963
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
963


